| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 11.33▲ | 11.25▲ | 11.21▲ | 11.37▼ | 10.93▲ |
| MA10 | 11.34▲ | 11.21▲ | 11.28▲ | 11.28▲ | 10.29▲ |
| MA20 | 11.28▲ | 11.32▲ | 11.37▼ | 10.95▲ | 10.09▲ |
| MA50 | 11.19▲ | 11.38▼ | 11.28▲ | 10.29▲ | 8.53▲ |
| MA100 | 11.29▲ | 11.28▲ | 11.09▲ | 10.09▲ | 8.41▲ |
| MA200 | 11.37▼ | 11.05▲ | 10.48▲ | 9.04▲ | 9.35▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.007▲ | -0.023▼ | 0.010▲ | 0.067▲ |
| RSI | 57.656▲ | 51.639▲ | 50.957▲ | 61.066▲ | 65.307▲ |
| STOCH | 38.927 | 43.665 | 26.194 | 74.942 | 79.961 |
| WILL %R | -66.667 | -32.000 | -46.875 | -25.203 | -10.000▲ |
| CCI | 10.181 | 55.410 | -5.694 | 88.597 | 166.931▲ |
|
Friday, April 24, 2026 11:05 AM
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes ...
|
|
Tuesday, April 21, 2026 08:20 AM
Updated results for the MAGEA4/8 bispecific, IMA401, across multiple cancers, highlighting its potential as part of a combination approach with the Company’s PRAME bispecific, IMA402, aimed at ...
|
|
Friday, April 17, 2026 12:02 PM
Individual experimental treatment attempt at Hopp Children’s Cancer Center Heidelberg (KiTZ) and Heidelberg University Hospital (UKHD) using a TCR T-cell therapy engineered with a PRAME-directed TCR ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/04/26 | 11.43 | 11.50 | 11.275 | 11.34 | 67,318 |
| 29/04/26 | 11.52 | 11.6494 | 11.00 | 11.20 | 267,803 |
| 28/04/26 | 11.35 | 11.645 | 11.32 | 11.59 | 209,948 |
| 27/04/26 | 11.40 | 11.65 | 11.30 | 11.35 | 354,951 |
| 24/04/26 | 11.15 | 11.44 | 10.88 | 11.35 | 232,653 |
| 23/04/26 | 11.27 | 11.30 | 10.97 | 11.15 | 310,899 |
| 22/04/26 | 11.30 | 11.30 | 11.11 | 11.26 | 176,814 |
| 21/04/26 | 11.25 | 11.285 | 10.965 | 11.18 | 275,255 |
| 20/04/26 | 11.09 | 11.29 | 10.80 | 11.25 | 260,141 |
| 17/04/26 | 11.10 | 11.30 | 11.0004 | 11.17 | 352,896 |
|
|
||||
|
|
||||
|
|